Prosecution Insights
Prosecution Insights
11 pending office actions • 9 art units • 9 examiners • 0 of 11 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (9%) |
| Double-patenting + other | 1 (9%) |
| No statute on record | 9 (82%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SKOKO III, JOHN JOSEPH | 2 | 52.8% | +58.4% |
| CREWS, JARET JAMES | 2 | 44.3% | +71.9% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.7% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.4% |
| BUTTICE, AUDREY L | 1 | 45.8% | +21.5% |
| LEE, HOI YAN NMN | 1 | 43.1% | +77.9% |
| ZARA, JANE J | 1 | 70.8% | +15.9% |
| STONEBRAKER, ALYSSA RAE | 1 | 54.4% | +52.8% |
| HUYNH, PHUONG N | 1 | 65.7% | +53.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17413965 | IMPROVED CELL-TARGETING BINDING MOLECULE | STONEBRAKER, ALYSSA RAE | 99d overdue |
| 17415759 | DRUG CONJUGATE | ZARA, JANE J | 30d overdue |
| 18044945 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | CHONG, KIMBERLY | 9d overdue |
| 18012694 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | CREWS, JARET JAMES | 1d overdue |
| 17629796 | Saponin derivatives with improved therapeutic window | CREWS, JARET JAMES | 7d |
| 18012710 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | PUTTLITZ, KARL J | 14d |
| 18012715 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | BUTTICE, AUDREY L | 15d |
| 17312193 | SAPONIN CONJUGATED TO EPITOPE-BINDING PROTEINS | HUYNH, PHUONG N | 22d |
| Art Unit | Apps |
|---|---|
| 1643 | 2 |
| 1691 | 2 |
| 1636 | 1 |
| 1646 | 1 |
| 1647 | 1 |
| 1693 | 1 |
| 1637 | 1 |
| 1642 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18044945 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | CHONG, KIMBERLY | 1636 | Other | Non-Final OA | 9d overdue | Pending | Mar 10, 2023 |
| 18012723 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | SKOKO III, JOHN JOSEPH | 1643 | DPOther | Non-Final OA | 69d | Pending | Dec 23, 2022 |
| 18012710 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | PUTTLITZ, KARL J | 1646 | Other | Final Rejection | 14d | Pending | Dec 23, 2022 |
| 18012741 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | SKOKO III, JOHN JOSEPH | 1643 | Other | Final Rejection | 26d | Pending | Dec 23, 2022 |
| 18012715 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | BUTTICE, AUDREY L | 1647 | Other | Final Rejection | 15d | Pending | Dec 23, 2022 |
| 18012694 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | CREWS, JARET JAMES | 1691 | §103 | Non-Final OA | 1d overdue | Pending | Dec 23, 2022 |
| 17629796 | Saponin derivatives with improved therapeutic window | CREWS, JARET JAMES | 1691 | Other | Non-Final OA | 7d | Pending | Jan 25, 2022 |
| 17629598 | BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY | LEE, HOI YAN NMN | 1693 | Other | Final Rejection | 34d | Pending | Jan 24, 2022 |
| 17415759 | DRUG CONJUGATE | ZARA, JANE J | 1637 | Other | Non-Final OA | 30d overdue | Pending | Jun 18, 2021 |
| 17413965 | IMPROVED CELL-TARGETING BINDING MOLECULE | STONEBRAKER, ALYSSA RAE | 1642 | Other | Non-Final OA | 99d overdue | Pending | Jun 15, 2021 |
| 17312193 | SAPONIN CONJUGATED TO EPITOPE-BINDING PROTEINS | HUYNH, PHUONG N | 1641 | Other | Non-Final OA | 22d | Pending | Jun 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial